For the best experience, we recommend visiting this site on a computer or a tablet in portrait mode.
NAOBIOS Viral Challenge
Spin the wheel, test your knowledge and win a surprise!
"*" indicates required fields
Since its creation, NAOBIOS has contributed to the development of:
For several years, NAOBIOS has been supporting innovative companies in the development and manufacturing of viral biological products, both in France and internationally.
Which stage of development can NAOBIOS support?
Our teams provide support throughout the entire project, from process and analytical method development to GMP manufacturing for clinical trials.
What types of clients does NAOBIOS support?
We work with organizations of all sizes, from innovative emerging biotech companies to international pharmaceutical companies.
Up to which biosafety level can NAOBIOS support your projects?
NAOBIOS can support projects requiring containment up to BSL-3, enabling the handling of highly pathogenic viruses under controlled conditions.
A well-controlled process development strategy helps to:
A well-controlled development strategy is a key factor for success.
How many years of expertise has NAOBIOS built in viral bioprocess development?
For more than 20 years, NAOBIOS has developed strong expertise in viral bioprocesses, from adherent and suspension cell culture to the production and purification of live and inactivated viruses.
How many oncolytic viruses are currently in preclinical development worldwide?
NAOBIOS can support oncolytic virus projects from bioprocess development through to GMP manufacturing of clinical batches from bench scale up to 200L or 200sqm.
source : Plan compétences biotech et innovations 2030, leem, mabdesign, Arthur Hunt Consulting
source : Plan compétences biotech et innovations 2030, leem, mabdesign, Arthur Hunt Consulting
Which criterion is essential for a biological product?
CQAs are central to biological product development and help ensure product quality, safety, and efficacy.
How many GMP batches of Human Viral Challenge Agents has NAOBIOS successfully manufactured and released?
NAOBIOS has successfully manufactured and released 36 GMP batches of HVCAs, including challenge agents for RSV, SARS-CoV-2, hMPV and influenza.